FDA panel backs XFG strain for 2026-27 COVID vaccine update
Source: SeekingAlpha
2026-05-29 05:00:10 ET
More on Moderna, Pfizer, etc.
- Pfizer: Reduced TrumpRx/Patent Risks Meet Accretive M&A Efforts - Reiterate Buy
- FQ1 Healthcare Dividend Roundup: Johnson & Johnson Keeps Outshining Pfizer
- Moderna, Inc. (MRNA) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
- Pfizer signs up to $10.5B oncology deal with China’s Innovent
- FDA AdCom panel to review and vote on next COVID shots
Read the full article on Seeking Alpha
For further details see:
FDA panel backs XFG strain for 2026-27 COVID vaccine update
Sanofi
NASDAQ: SNY
SNY Trading
1.75% G/L:
$45.035 Last:
1,382,086 Volume:
$45 Open:
SNY Latest News
June 03, 2026 09:13:54 am
Sanofi aims to cut AI-driven drug development timelines in half with Snowflake
SNY Stock Data
$119,804,457,217
2,430,957,423
N/A
389
N/A
Pharmaceuticals
Healthcare
FR
Paris
